Prognostic and Predictive Value of ct DNA for Metastatic Uveal Melanoma: A Systematic Review and Meta‐Analysis
Pigment Cell & Melanoma Research · 2025
DOI: 10.1111/pcmr.70047 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Pigment Cell & Melanoma Research, 2025. Verfasst von Mariana Macambira Noronha und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Universidade Federal do Ceará, Fortaleza, Ceará, Brazil. Hauptthemen laut MEDLINE: Melanoma, Uveal Neoplasms, Circulating Tumor DNA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Metastatic uveal melanoma (mUM) is a rare disease associated with poor prognosis and limited therapeutic options. Recent studies showed that detecting ctDNA is feasible and can aid treatment decisions for patients with mUM. We systematically searched PubMed, EMBASE, and Cochrane databases for eligible studies published up to May 2025 that included patients with mUM and reported data on the association between ctDNA and survival outcomes (OS and PFS). Statistical analyses were performed using Review Manager 5.4 software. Of the initial 450 records, seven studies met eligibility, including 518 patients with mUM. At baseline, ctDNA positivity was associated with significantly worse PFS (HR 2.34; 95% CI 1.56–3.51; p < 0.01; I 2 = 0%) and OS (HR 3.32; 95% CI 2.09–5.29; p < 0.01; I 2 = 48%). In patients treated with tebentafusp, ctDNA clearance was associated with superior OS (HR 0.19; 95% CI 0.07–0.49; p < 0.01; I 2 = 46%) and any decrease in ctDNA was associated with better OS (HR 0.42; 95% CI 0.22–0.80; p < 0.01; I 2 = 0%). This meta‐analysis underscores ctDNA as a potential predictor of worse survival in patients with mUM, highlighting its potential to refine risk stratification and guide treatment strategies. Trial Registration: International Prospective Register of Systematic Reviews (PROSPERO): CRD42025638076
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Sciences, Universidade Federal do Ceará, Fortaleza, Ceará, Brazil.
- Department of Medical Sciences, Universidade Federal Fluminense, Niteroi, Rio de Janeiro, Brazil.
- Department of Medical Sciences, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
- Sarcoma Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
- Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, Florida, USA.
- Department of Medicine, University of Toronto, Toronto, Canada.
ORCID-Profile: Mariana Macambira Noronha, Luís Felipe Leite da Silva, Luiz Felipe Costa Almeida, Pedro Robson Costa Passos, Pedro Cotta Abrahão Reis, Valbert Oliveira Costa Filho, Mauricio F S A Ribeiro, Samuel D Saibil, Erick F Saldanha
Zitieren
APA
Noronha, M. M., da Silva, L. F. L., Almeida, L. F. C., Passos, P. R. C., Reis, P. C. A., Conrado, J. E. P., Filho, V. O. C., da Conceição, L. D., Ribeiro, M. F. S. A., Saibil, S. D., & Saldanha, E. F. (2025). Prognostic and Predictive Value of ct DNA for Metastatic Uveal Melanoma: A Systematic Review and Meta‐Analysis. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.70047
Vancouver
Noronha MM, da Silva LFL, Almeida LFC, Passos PRC, Reis PCA, Conrado JEP, et al. Prognostic and Predictive Value of ct DNA for Metastatic Uveal Melanoma: A Systematic Review and Meta‐Analysis. Pigment Cell & Melanoma Research. 2025. doi:10.1111/pcmr.70047
BibTeX
@article{Noronha2025,
author = {Noronha, Mariana Macambira and da Silva, Luís Felipe Leite and Almeida, Luiz Felipe Costa and Passos, Pedro Robson Costa and Reis, Pedro Cotta Abrahão and Conrado, João Evangelista Ponte and Filho, Valbert Oliveira Costa and da Conceição, Lucas Diniz and Ribeiro, Mauricio F S A and Saibil, Samuel D and Saldanha, Erick F},
title = {Prognostic and Predictive Value of ct DNA for Metastatic Uveal Melanoma: A Systematic Review and Meta‐Analysis},
journal = {Pigment Cell & Melanoma Research},
year = {2025},
doi = {10.1111/pcmr.70047}
}
EUVIMED